SteinCares Deal Leads Lupin’s Ranibizumab Into Latin America

Lupin’s Lucentis Biosimilar Is Licensed For LATAM Region

 
• By Dave Wallace
  
Lupin is targeting Latin America with the ranibizumab deal (Shutterstock)

More from Deals

More from Products